drugset / Trial / NCT07025577
A Study to Assess the Tolerability and Safety of Subcutaneously (SC) Administered Immunoglobulin G (IgG) With Varying Injection Conditions
RandomizedParallel-groupOpen-labelBasic science
Summary
This study will evaluate the safety and tolerability of SC administration of IgG in healthy participants.
Timeline
- Start
- 2025-06-02
- Primary completion
- 2025-08-08
- Completion
- 2025-09-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Immunoglobulin G | Protein / enzyme biologic | — | Subcutaneous |
Indications
No indication recorded.